Search Results

Your search for Juliet Elizabeth Wolford, MD, on Ovarian Cancer: The Cost of Care matches 1 pages

Showing 1 - 1

By Juliet Elizabeth Wolford, MD, on Ovarian Cancer: The Cost of Care / 2018 ASCO Annual Meeting

Juliet Elizabeth Wolford, MD, on Ovarian Cancer: The Cost of Care

Juliet Elizabeth Wolford, MD, of the University of California, Irvine, discusses the cost-effectiveness of various types of maintenance therapy in advanced ovarian cancer: paclitaxel, bevacizumab, niraparib, rucaparib, olaparib, and pembrolizumab (Abstract 5508).

Apr

Today In Oncology

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETS

Potential Protective Effects of Aspirin Against Colorectal Cancer

FDA Grants Accelerated Approval to Tovorafenib for Patients With Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

Induction and Concurrent Vismodegib With Radiation Therapy for Locally Advanced Unresectable Basal Cell Carcinoma